Biotechnology and nanotechnology

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Type

2 facets displayed. 0 facets selected.

Geography

2 facets displayed. 0 facets selected.

Survey or statistical program

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (4)

All (4) ((4 results))

  • Articles and reports: 88F0006X2007006
    Description:

    This descriptive working paper provides highlights from the Biotechnology Use and Development Survey 2005. Data on innovative biotechnology firms are presented by region, sectors and firm size. The data include firm revenues, R&D activities, human resources, firm financing, age of firms, country of control and the proportion of publicly traded firms.

    Release date: 2007-12-05

  • Articles and reports: 88-003-X200700210325
    Geography: Canada
    Description:

    Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.

    Release date: 2007-10-09

  • Stats in brief: 88-001-X20070039614
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2005/2006 were collected from selected federal government departments and agencies. This information contributes to the work of the Canadian Biotechnology Strategy. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2007-05-11

  • Articles and reports: 88-003-X20070019620
    Geography: Canada, Province or territory
    Description:

    Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.

    Release date: 2007-05-10
Data (0)

Data (0) (0 results)

No content available at this time.

Analysis (4)

Analysis (4) ((4 results))

  • Articles and reports: 88F0006X2007006
    Description:

    This descriptive working paper provides highlights from the Biotechnology Use and Development Survey 2005. Data on innovative biotechnology firms are presented by region, sectors and firm size. The data include firm revenues, R&D activities, human resources, firm financing, age of firms, country of control and the proportion of publicly traded firms.

    Release date: 2007-12-05

  • Articles and reports: 88-003-X200700210325
    Geography: Canada
    Description:

    Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.

    Release date: 2007-10-09

  • Stats in brief: 88-001-X20070039614
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2005/2006 were collected from selected federal government departments and agencies. This information contributes to the work of the Canadian Biotechnology Strategy. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2007-05-11

  • Articles and reports: 88-003-X20070019620
    Geography: Canada, Province or territory
    Description:

    Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.

    Release date: 2007-05-10
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: